Several previously published reports revealed that m6A methyltransferases and demethylases both had oncogenic functions by regulating different targets in breast cancer, including METTL3 (16), METTL14 (17), FTO (15), and ALKBH5 (31). This evidence concerns the gene MBD2 and breast carcinoma.